These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 23266729

  • 1. Sulfated derivatives of 20(S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators.
    Fu BD, Bi WY, He CL, Zhu W, Shen HQ, Yi PF, Wang L, Wang DC, Wei XB.
    Fitoterapia; 2013 Jan; 84():303-7. PubMed ID: 23266729
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells.
    Yi PF, Bi WY, Shen HQ, Wei Q, Zhang LY, Dong HB, Bai HL, Zhang C, Song Z, Qin QQ, Lv S, Wu SC, Fu BD, Wei XB.
    Eur J Pharmacol; 2013 Jul 15; 712(1-3):60-6. PubMed ID: 23665488
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes.
    Choi WY, Lim HW, Lim CJ.
    J Pharm Pharmacol; 2013 Feb 15; 65(2):310-6. PubMed ID: 23278699
    [Abstract] [Full Text] [Related]

  • 4. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
    Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH.
    Planta Med; 2006 Jun 15; 72(7):627-33. PubMed ID: 16673329
    [Abstract] [Full Text] [Related]

  • 5. 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity.
    Liu J, Shiono J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3320-3. PubMed ID: 19428246
    [Abstract] [Full Text] [Related]

  • 6. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
    Singh P, Kim YJ, Singh H, Ahn S, Castro-Aceituno V, Yang DC.
    Int J Nanomedicine; 2017 Jun 15; 12():4073-4084. PubMed ID: 28603419
    [Abstract] [Full Text] [Related]

  • 7. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells.
    Lv S, Yi PF, Shen HQ, Zhang LY, Dong HB, Wu SC, Xia F, Guo X, Wei XB, Fu BD.
    Immunopharmacol Immunotoxicol; 2014 Feb 15; 36(1):43-51. PubMed ID: 24294901
    [Abstract] [Full Text] [Related]

  • 8. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L, Lee J, Jang JH, Lee SH, Nan MH, Oh BC, Lee SG, Kim HH, Soung NK, Ahn JS, Kim BY.
    Bone; 2012 Jun 15; 50(6):1207-13. PubMed ID: 22484180
    [Abstract] [Full Text] [Related]

  • 9. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway.
    Kim BH, Lee YG, Park TY, Kim HB, Rhee MH, Cho JY.
    Planta Med; 2009 Mar 15; 75(4):321-6. PubMed ID: 19145554
    [Abstract] [Full Text] [Related]

  • 10. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
    Liu J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R.
    Fitoterapia; 2010 Oct 15; 81(7):902-5. PubMed ID: 20554003
    [Abstract] [Full Text] [Related]

  • 11. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
    Zhang C, Yu H, Hou J.
    Zhongguo Zhong Yao Za Zhi; 2011 Jun 15; 36(12):1670-4. PubMed ID: 22007558
    [Abstract] [Full Text] [Related]

  • 12. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor.
    Niu CS, Yeh CH, Yeh MF, Cheng JT.
    Horm Metab Res; 2009 Apr 15; 41(4):271-6. PubMed ID: 19048455
    [Abstract] [Full Text] [Related]

  • 13. Production of the Rare Ginsenoside Rh2-MIX (20(S)-Rh2, 20(R)-Rh2, Rk2, and Rh3) by Enzymatic Conversion Combined with Acid Treatment and Evaluation of Its Anti-Cancer Activity.
    Song BK, Kim KM, Choi KD, Im WT.
    J Microbiol Biotechnol; 2017 Jul 28; 27(7):1233-1241. PubMed ID: 28478658
    [Abstract] [Full Text] [Related]

  • 14. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
    Mathiyalagan R, Wang C, Kim YJ, Castro-Aceituno V, Ahn S, Subramaniyam S, Simu SY, Jiménez-Pérez ZE, Yang DC, Jung SK.
    Molecules; 2019 Nov 29; 24(23):. PubMed ID: 31795352
    [Abstract] [Full Text] [Related]

  • 15. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
    Lee IA, Hyam SR, Jang SE, Han MJ, Kim DH.
    J Agric Food Chem; 2012 Sep 26; 60(38):9595-602. PubMed ID: 22849695
    [Abstract] [Full Text] [Related]

  • 16. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
    Popovich DG, Kitts DD.
    J Biochem Mol Toxicol; 2004 Sep 26; 18(3):143-9. PubMed ID: 15252870
    [Abstract] [Full Text] [Related]

  • 17. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte.
    Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, Ha J, Kim MS, Kwon DY.
    Biochem Biophys Res Commun; 2007 Dec 28; 364(4):1002-8. PubMed ID: 17971295
    [Abstract] [Full Text] [Related]

  • 18. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
    Popovich DG, Kitts DD.
    Can J Physiol Pharmacol; 2004 Mar 28; 82(3):183-90. PubMed ID: 15052284
    [Abstract] [Full Text] [Related]

  • 19. Antiallergic activity of ginsenoside Rh2.
    Park EK, Choo MK, Kim EJ, Han MJ, Kim DH.
    Biol Pharm Bull; 2003 Nov 28; 26(11):1581-4. PubMed ID: 14600405
    [Abstract] [Full Text] [Related]

  • 20. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.
    Kitts DD, Popovich DG, Hu C.
    Can J Physiol Pharmacol; 2007 Nov 28; 85(11):1173-83. PubMed ID: 18066119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.